PTCT
#1240
PTC Therapeutics, Inc. - Common Stock
70.0 9 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.40%
Changement Mensuel
+4.33%
Evolution sur 6 mois
+4.49%
Changement Annuel
+41.68%
Clôture Précédente
71.8 1
Open
70.0 9
Low
70.0 9
High
70.0 9
Volume
88
Financials
- Market Capitalization 5.85 B
- Employee 991
- Founded 1998
- CEO Matthew B. Klein
- Website www.ptcbio.com
- Headquarter Delaware, United States
- FIGI BBG000QT15P7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-151.06
ratio cours/chiffre d'affaires
7.09
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1225 |  BLTE Belite Bio Inc - American Depositary Shares | 151.72 USD | -3.37% | -5.80% | -3.71% | +144.00% | 5.97 B USD | ||
| 1232 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 105.84 USD | -5.11% | -3.85% | +0.19% | +352.50% | 5.92 B USD | ||
| 1248 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 59.99 USD | -3.13% | -1.28% | -5.09% | +47.07% | 5.81 B USD | ||
| 1276 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 280.49 USD | -1.42% | -2.02% | -2.32% | +49.90% | 5.59 B USD |